How Zifo’s AI authoring platform could reshape clinical and CMC documentation
Regulatory teams need speed, but AI needs auditability. Zifo’s authoring platform tests whether pharma can have both.
How Veld Pharmaceuticals and Chiesi Farmaceutici are expanding rare disease therapy access in Africa
Chiesi Farmaceutici and Veld Pharmaceuticals expand rare disease therapy access across Africa. Discover what this means for market access and regulation.
Why CTIS is betting FDA’s E2B(R3) deadline will reshape pharmacovigilance software demand;
CTIS launches Trial SafetyXchange to help pharma firms meet the FDA E2B(R3) deadline. Read what it changes for safety reporting teams.